Skip to main content
SpringerLink
Log in

Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

  • Correspondence
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A Correspondence to this article was published on 07 June 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Relationship between EZH2 function and BAP1 status in uveal melanoma.

References

  1. LaFave, L.M. et al. Nat. Med. 21, 1344–1349 (2015).

    Article  CAS  Google Scholar 

  2. Harbour, J.W. et al. Science 330, 1410–1413 (2010).

    Article  CAS  Google Scholar 

  3. Margueron, R. & Reinberg, D. Nature 469, 343–349 (2011).

    Article  CAS  Google Scholar 

  4. Amirouchene-Angelozzi, N. et al. Mol. Oncol. 8, 1508–1520 (2014).

    Article  CAS  Google Scholar 

  5. Laurent, C. et al. Mol. Oncol. 7, 625–636 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by INSERM grant EpiUM (M.-H.S., S.R.-R. and R.M.) and InCA grant UMCURE (M.-H.S. and S.R.-R.). The authors thank P.A. Van Der Velden (Leiden University) for kindly providing OMM1 and OMM2.5 cells.

Author information

Author notes

  1. Marie Schoumacher and Stéphanie Le Corre: These authors contributed equally to this work.

Authors and Affiliations

  1. Institut Curie, Paris Sciences et Lettres Research University, Paris, France

    Marie Schoumacher, Stéphanie Le Corre, Alexandre Houy, Eskeatnaf Mulugeta, Marc-Henri Stern, Sergio Roman-Roman & Raphaël Margueron

  2. Department of Translational Research, Paris, France

    Marie Schoumacher & Sergio Roman-Roman

  3. Institut National de la Santé et de la Recherche Médicale (INSERM) U934–Centre National de Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR), Paris, 3215, France

    Stéphanie Le Corre, Eskeatnaf Mulugeta & Raphaël Margueron

  4. INSERM U830, Paris, France

    Alexandre Houy & Marc-Henri Stern

Authors
  1. Marie Schoumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stéphanie Le Corre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandre Houy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eskeatnaf Mulugeta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marc-Henri Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sergio Roman-Roman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raphaël Margueron
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.S. and S.L.C. performed experiments and prepared the figures; E.M. analyzed the ChIP-seq data; A.H. analyzed the transcriptomic data; M.S., M.-H.S., S.R.-R. and R.M. analyzed data and directed the study; M.S., S.R.-R. and R.M. wrote the manuscript; and all authors reviewed the manuscript and provided final approval for submission.

Corresponding author

Correspondence to Raphaël Margueron.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Figure 1 and Supplementary Table 1 (PDF 354 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schoumacher, M., Le Corre, S., Houy, A. et al. Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status. Nat Med 22, 577–578 (2016). https://doi.org/10.1038/nm.4098

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4098

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation